These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

435 related articles for article (PubMed ID: 25337656)

  • 1. Partial blockade of Kv2.1 channel potentiates GLP-1's insulinotropic effects in islets and reduces its dose required for improving glucose tolerance in type 2 diabetic male mice.
    Sukma Rita R; Dezaki K; Kurashina T; Kakei M; Yada T
    Endocrinology; 2015 Jan; 156(1):114-23. PubMed ID: 25337656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of voltage-gated potassium channels Kv2.1 and Kv2.2 in the regulation of insulin and somatostatin release from pancreatic islets.
    Li XN; Herrington J; Petrov A; Ge L; Eiermann G; Xiong Y; Jensen MV; Hohmeier HE; Newgard CB; Garcia ML; Wagner M; Zhang BB; Thornberry NA; Howard AD; Kaczorowski GJ; Zhou YP
    J Pharmacol Exp Ther; 2013 Feb; 344(2):407-16. PubMed ID: 23161216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glucagon-like peptide-1 and islet lipolysis.
    Sörhede Winzell M; Ahrén B
    Horm Metab Res; 2004; 36(11-12):795-803. PubMed ID: 15655711
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The tarantula toxin GxTx detains K
    Tilley DC; Angueyra JM; Eum KS; Kim H; Chao LH; Peng AW; Sack JT
    J Gen Physiol; 2019 Mar; 151(3):292-315. PubMed ID: 30397012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potentiation of insulin secretion and improvement of glucose intolerance by combining a novel G protein-coupled receptor 40 agonist DS-1558 with glucagon-like peptide-1 receptor agonists.
    Nakashima R; Yano T; Ogawa J; Tanaka N; Toda N; Yoshida M; Takano R; Inoue M; Honda T; Kume S; Matsumoto K
    Eur J Pharmacol; 2014 Aug; 737():194-201. PubMed ID: 24858371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new orally available glucagon-like peptide-1 receptor agonist, biotinylated exendin-4, displays improved hypoglycemic effects in db/db mice.
    Jin CH; Chae SY; Son S; Kim TH; Um KA; Youn YS; Lee S; Lee KC
    J Control Release; 2009 Feb; 133(3):172-7. PubMed ID: 18977255
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel glucagon-like peptide-1 (GLP-1) analog (Val8)GLP-1 results in significant improvements of glucose tolerance and pancreatic beta-cell function after 3-week daily administration in obese diabetic (ob/ob) mice.
    Green BD; Lavery KS; Irwin N; O'harte FP; Harriott P; Greer B; Bailey CJ; Flatt PR
    J Pharmacol Exp Ther; 2006 Aug; 318(2):914-21. PubMed ID: 16648370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The novel GLP-1-gastrin dual agonist, ZP3022, increases β-cell mass and prevents diabetes in db/db mice.
    Fosgerau K; Jessen L; Lind Tolborg J; Østerlund T; Schæffer Larsen K; Rolsted K; Brorson M; Jelsing J; Skovlund Ryge Neerup T
    Diabetes Obes Metab; 2013 Jan; 15(1):62-71. PubMed ID: 22862961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SNAP-25(1-180) enhances insulin secretion by blocking Kv2.1 channels in rat pancreatic islet beta-cells.
    Zhuang GQ; Wu W; Liu F; Ma JL; Luo YX; Xiao ZX; Liu Y; Wang W; He Y
    Biochem Biophys Res Commun; 2009 Feb; 379(4):812-6. PubMed ID: 19103161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kv2.1 ablation alters glucose-induced islet electrical activity, enhancing insulin secretion.
    Jacobson DA; Kuznetsov A; Lopez JP; Kash S; Ammälä CE; Philipson LH
    Cell Metab; 2007 Sep; 6(3):229-35. PubMed ID: 17767909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glucagon-like peptide-2 receptor modulates islet adaptation to metabolic stress in the ob/ob mouse.
    Bahrami J; Longuet C; Baggio LL; Li K; Drucker DJ
    Gastroenterology; 2010 Sep; 139(3):857-68. PubMed ID: 20546737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kv2 channel regulation of action potential repolarization and firing patterns in superior cervical ganglion neurons and hippocampal CA1 pyramidal neurons.
    Liu PW; Bean BP
    J Neurosci; 2014 Apr; 34(14):4991-5002. PubMed ID: 24695716
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biological activity of AC3174, a peptide analog of exendin-4.
    Hargrove DM; Kendall ES; Reynolds JM; Lwin AN; Herich JP; Smith PA; Gedulin BR; Flanagan SD; Jodka CM; Hoyt JA; McCowen KM; Parkes DG; Anderson CM
    Regul Pept; 2007 Jun; 141(1-3):113-9. PubMed ID: 17292977
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of Kv2.1 voltage-dependent K+ channels in pancreatic beta-cells enhances glucose-dependent insulin secretion.
    MacDonald PE; Sewing S; Wang J; Joseph JW; Smukler SR; Sakellaropoulos G; Wang J; Saleh MC; Chan CB; Tsushima RG; Salapatek AM; Wheeler MB
    J Biol Chem; 2002 Nov; 277(47):44938-45. PubMed ID: 12270920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glucagon-like-peptide-1 (7-36) amide improves glucose sensitivity in beta-cells of NOD mice.
    Linn T; Schneider K; Göke B; Federlin K
    Acta Diabetol; 1996 Mar; 33(1):19-24. PubMed ID: 8777280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Control of voltage-gated potassium channel Kv2.2 expression by pyruvate-isocitrate cycling regulates glucose-stimulated insulin secretion.
    Jensen MV; Haldeman JM; Zhang H; Lu D; Huising MO; Vale WW; Hohmeier HE; Rosenberg P; Newgard CB
    J Biol Chem; 2013 Aug; 288(32):23128-40. PubMed ID: 23788641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exendin-4 ameliorates diabetic symptoms through activation of glucokinase.
    Dhanesha N; Joharapurkar A; Shah G; Dhote V; Kshirsagar S; Bahekar R; Jain M
    J Diabetes; 2012 Dec; 4(4):369-77. PubMed ID: 22356440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemoselective tarantula toxins report voltage activation of wild-type ion channels in live cells.
    Tilley DC; Eum KS; Fletcher-Taylor S; Austin DC; Dupré C; Patrón LA; Garcia RL; Lam K; Yarov-Yarovoy V; Cohen BE; Sack JT
    Proc Natl Acad Sci U S A; 2014 Nov; 111(44):E4789-96. PubMed ID: 25331865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exendin-4 increases bone mineral density in type 2 diabetic OLETF rats potentially through the down-regulation of SOST/sclerostin in osteocytes.
    Kim JY; Lee SK; Jo KJ; Song DY; Lim DM; Park KY; Bonewald LF; Kim BJ
    Life Sci; 2013 Mar; 92(10):533-40. PubMed ID: 23357248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Administration of an acylated GLP-1 and GIP preparation provides added beneficial glucose-lowering and insulinotropic actions over single incretins in mice with Type 2 diabetes and obesity.
    Gault VA; Kerr BD; Harriott P; Flatt PR
    Clin Sci (Lond); 2011 Aug; 121(3):107-17. PubMed ID: 21332446
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.